Pharmacological Targets of Hypertension
- 2 November 2019
- book chapter
- Published by Springer Nature
- p. 179-191
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: Recommendations for patient informationInternational Journal of Cardiology, 2013
- The role of the ENaC-regulatory complex in aldosterone-mediated sodium transportMolecular and Cellular Endocrinology, 2012
- Angiotensin Receptor Blockers: Pharmacology, Efficacy, and SafetyThe Journal of Clinical Hypertension, 2011
- Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta‐analysisDiabetic Medicine, 2007
- Direct Renin Inhibition with Aliskiren in Hypertension and Target Organ DamageClinical Journal of the American Society of Nephrology, 2006
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Adverse Effects of ??1-Adrenergic Blocking DrugsDrug Safety, 1994
- How Do Loop Diuretics Act?Drugs, 1991
- Mechanism of antihypertensive effect of thiazide diureticsAmerican Heart Journal, 1978